A citation-based method for searching scientific literature

Madison Pereira, Kathy Matuszewska, Colin Jamieson, Jim Petrik. Front Endocrinol (Lausanne) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.
Robert L Coleman, Russell R Broaddus, Diane C Bodurka, Judith K Wolf, Thomas W Burke, John J Kavanagh, Charles F Levenback, David M Gershenson. Gynecol Oncol 2006
77
100

Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.
Srinivas Malladi, Danilo G Macalinao, Xin Jin, Lan He, Harihar Basnet, Yilong Zou, Elisa de Stanchina, Joan Massagué. Cell 2016
363
100

Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth.
Karen McLean, Lijun Tan, Danielle E Bolland, Lan G Coffman, Luke F Peterson, Moshe Talpaz, Nouri Neamati, Ronald J Buckanovich. Oncogene 2019
34
100

Post-transcriptional regulations of cancer stem cell homeostasis.
Nabila Berabez, Sébastien Durand, Mathieu Gabut. Curr Opin Oncol 2019
5
100

Influence of Innate Immunity on Cancer Cell Stemness.
Anna Pastò, Francesca Maria Consonni, Antonio Sica. Int J Mol Sci 2020
12
100

Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment.
Kosuke Akiyama, Noritaka Ohga, Yasuhiro Hida, Taisuke Kawamoto, Yoshihiro Sadamoto, Shuhei Ishikawa, Nako Maishi, Tomoshige Akino, Miyako Kondoh, Aya Matsuda,[...]. Am J Pathol 2012
106
100


Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma.
Terence Kin-Wah Lee, Vincent Chi-Ho Cheung, Ping Lu, Eunice Yuen Ting Lau, Stephanie Ma, Kwan Ho Tang, Man Tong, Jessica Lo, Irene Oi Lin Ng. Hepatology 2014
129
100

Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.
Jin-Gyoung Jung, Alexander Stoeck, Bin Guan, Ren-Chin Wu, Heng Zhu, Seth Blackshaw, Ie-Ming Shih, Tian-Li Wang. PLoS Genet 2014
44
100

Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.
Jessica Gobbo, Guillaume Marcion, Marine Cordonnier, Alexandre M M Dias, Nicolas Pernet, Arlette Hammann, Sarah Richaud, Hajare Mjahed, Nicolas Isambert, Victor Clausse,[...]. J Natl Cancer Inst 2015
110
100

Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
Adam D Steg, Kerri S Bevis, Ashwini A Katre, Angela Ziebarth, Zachary C Dobbin, Ronald D Alvarez, Kui Zhang, Michael Conner, Charles N Landen. Clin Cancer Res 2012
250
100

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.
Junzo Hamanishi, Masaki Mandai, Masashi Iwasaki, Taku Okazaki, Yoshimasa Tanaka, Ken Yamaguchi, Toshihiro Higuchi, Haruhiko Yagi, Kenji Takakura, Nagahiro Minato,[...]. Proc Natl Acad Sci U S A 2007
100

Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression.
Kristy K Ward, Isabelle Tancioni, Christine Lawson, Nichol L G Miller, Christine Jean, Xiao Lei Chen, Sean Uryu, Josephine Kim, David Tarin, Dwayne G Stupack,[...]. Clin Exp Metastasis 2013
75
100

SOX2 is required to maintain cancer stem cells in ovarian cancer.
Yiping Wen, Yaya Hou, Zaiju Huang, Jing Cai, Zehua Wang. Cancer Sci 2017
44
100



First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors.
Gerald Falchook, Jeffrey Infante, Hendrik-Tobias Arkenau, Manish R Patel, Emma Dean, Erkut Borazanci, Andrew Brenner, Natalie Cook, Juanita Lopez, Shubham Pant,[...]. EClinicalMedicine 2021
25
100

Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells.
Ayesha B Alvero, Michele K Montagna, Jennie C Holmberg, Vinicius Craveiro, David Brown, Gil Mor. Mol Cancer Ther 2011
88
100




Latent bone metastasis in breast cancer tied to Src-dependent survival signals.
Xiang H-F Zhang, Qiongqing Wang, William Gerald, Clifford A Hudis, Larry Norton, Marcel Smid, John A Foekens, Joan Massagué. Cancer Cell 2009
491
100

Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at divergent nodes.
Jeffrey J Wallin, Jane Guan, Kyle A Edgar, Wei Zhou, Ross Francis, Anthony C Torres, Peter M Haverty, Jeffrey Eastham-Anderson, Sabrina Arena, Alberto Bardelli,[...]. PLoS One 2012
40
100

The identification of the biological characteristics of human ovarian cancer stem cells.
H C Yan, L S Fang, J Xu, Y Y Qiu, X M Lin, H X Huang, Q Y Han. Eur Rev Med Pharmacol Sci 2014
26
100

Role of Magmas in protein transport and human mitochondria biogenesis.
Devanjan Sinha, Neha Joshi, Balasubramanyam Chittoor, Priyanka Samji, Patrick D'Silva. Hum Mol Genet 2010
46
100

Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor-Based Immunotherapy and Chemotherapy.
Rüdiger Klapdor, Shuo Wang, Ulrich Hacker, Hildegard Büning, Michael Morgan, Thilo Dörk, Peter Hillemanns, Axel Schambach. Hum Gene Ther 2017
37
100


An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population.
Ram K Singh, Ajit Dhadve, Asmita Sakpal, Abhijit De, Pritha Ray. Sci Rep 2016
23
100

The role of cancer stem cells in the modulation of anti-tumor immune responses.
Cristina Maccalli, Kakil Ibrahim Rasul, Mamoun Elawad, Soldano Ferrone. Semin Cancer Biol 2018
48
100

Ovarian cancer stem cells and targeted therapy.
Vahideh Keyvani, Moein Farshchian, Seyed-Alireza Esmaeili, Hadi Yari, Meysam Moghbeli, Seyed-Reza Kazemi Nezhad, Mohammad Reza Abbaszadegan. J Ovarian Res 2019
25
100

Immunobiology of mesenchymal stem cells.
S Ma, N Xie, W Li, B Yuan, Y Shi, Y Wang. Cell Death Differ 2014
454
100


Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications.
Francesca Nazio, Matteo Bordi, Valentina Cianfanelli, Franco Locatelli, Francesco Cecconi. Cell Death Differ 2019
141
100

Dendritic cell rehab: new strategies to unleash therapeutic immunity in ovarian cancer.
Chang-Suk Chae, Eli Teran-Cabanillas, Juan R Cubillos-Ruiz. Cancer Immunol Immunother 2017
15
100

Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Anil Belur Nagaraj, Peronne Joseph, Olga Kovalenko, Sareena Singh, Amy Armstrong, Raymond Redline, Kimberly Resnick, Kristine Zanotti, Steven Waggoner, Analisa DiFeo. Oncotarget 2015
128
100

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.
M Saegusa, M Hashimura, T Yoshida, I Okayasu. Br J Cancer 2001
128
100

KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.
Yvonne T Tsang, Michael T Deavers, Charlotte C Sun, Suet-Yan Kwan, Eric Kuo, Anais Malpica, Samuel C Mok, David M Gershenson, Kwong-Kwok Wong. J Pathol 2013
70
100

Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer.
Don S Dizon, Lars Damstrup, Neil J Finkler, Ulrik Lassen, Paul Celano, Ros Glasspool, Elizabeth Crowley, Henri S Lichenstein, Poul Knoblach, Richard T Penson. Int J Gynecol Cancer 2012
47
100

Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress.
Carman K M Ip, Shan-Shan Li, Matthew Y H Tang, Samuel K H Sy, Yong Ren, Ho Cheung Shum, Alice S T Wong. Sci Rep 2016
56
100

Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.
Appalaraju Jaggupilli, Eyad Elkord. Clin Dev Immunol 2012
300
100

Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
Kha-Liang Lee, Yung-Che Kuo, Yuan-Soon Ho, Yen-Hua Huang. Cancers (Basel) 2019
82
100

Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
C Guo, X Wang, L-P Chen, M Li, M Li, Y-H Hu, W-H Ding, X Wang. Eur Rev Med Pharmacol Sci 2018
30
100

Ovarian cancer stem-like cells elicit the polarization of M2 macrophages.
Qing Zhang, Da-Jun Cai, Bin Li. Mol Med Rep 2015
22
100


Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
Da Yang, Yan Sun, Limei Hu, Hong Zheng, Ping Ji, Chad V Pecot, Yanrui Zhao, Sheila Reynolds, Hanyin Cheng, Rajesha Rupaimoole,[...]. Cancer Cell 2013
296
100

Mitophagy, Mitochondrial Homeostasis, and Cell Fate.
Kaili Ma, Guo Chen, Wenhui Li, Oliver Kepp, Yushan Zhu, Quan Chen. Front Cell Dev Biol 2020
83
100

Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy.
Ilio Vitale, Antonella Sistigu, Gwenola Manic, Nils-Petter Rudqvist, Zlatko Trajanoski, Lorenzo Galluzzi. Trends Cell Biol 2019
44
100

Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752.
XiuXiu Chen, LiHua Gong, RongYing Ou, ZhenZhen Zheng, JinYan Chen, FengFeng Xie, XiaoXiu Huang, JianGe Qiu, WenJi Zhang, QiWei Jiang,[...]. Gynecol Oncol 2016
38
100

ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients.
Roger W McGilvray, Robert A Eagle, Phil Rolland, Insiya Jafferji, John Trowsdale, Lindy G Durrant. Int J Cancer 2010
60
100

Ovarian cancer stem cell-specific gene expression profiling and targeted drug prescreening.
Yuting Huang, Baohui Ju, Jing Tian, Fenghua Liu, Hu Yu, Huiting Xiao, Xiangyu Liu, Wenxin Liu, Zhi Yao, Quan Hao. Oncol Rep 2014
19
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.